Key result
Pulsed field ablation is linked to ~75% higher peak troponin vs cryoballoon ablation.
Why the study?
The extent of myocardial injury and systemic inflammatory or thrombotic response after pulmonary vein isolation for atrial fibrillation may vary depending on the ablation energy modality and catheter diameter, but this has not been characterized.
Does pulsed field ablation compared to cryoballoon ablation alter the magnitude and temporal profile of myocardial injury, systemic inflammation, and thrombotic biomarkers following pulmonary vein isolation?
Observational (n=70)
No
Does pulsed field ablation compared to cryoballoon ablation alter the magnitude and temporal profile of myocardial injury, systemic inflammation, and thrombotic biomarkers following pulmonary vein isolation?
Pulsed field ablation induces a faster and significantly greater peak in myocardial injury biomarkers (hs-cTn) compared to cryoballoon ablation, while cryoballoon ablation triggers a greater systemic inflammatory response (CRP), with neither negatively impacting thrombogenicity or renal function.
Answers are grounded in this paper and cite their sources.
Higher troponin release after pulsed field ablation should not yet change ablation selection; leaves open whether differential biomarker profiles affect outcomes.
Introduction: Pulmonary vein isolation (PVI) for atrial fibrillation (AF) induces myocardial necrosis. The extent of myocardial injury and systemic inflammatory or thrombotic response may vary depending on the ablation energy modality. It is not known whether the maximum diameter of ‘single shot” ablation catheters influences the magnitude of biomarker release. We aimed to study the temporal profiles of cardiac (high-sensitivity cardiac troponin I, hs-cTn), inflammatory (C-reactive protein, CRP), and thrombotic (D-dimer) biomarkers, as well as creatinine, within 24 hours of PVI, using cryogenic (CBA) or pulsed field energy (PFA). Materials and methods: We prospectively studied consecutive patients with non-permanent AF undergoing first-time PVI by CBA or PFA. Data were collected on the demographic and clinical characteristics, echocardiographic and procedural parameters, and biomarker levels. Blood samples were collected pre-procedure, 6-8 hours post-procedure, and 20-22 hours post-procedure. Repeated measures ANOVA was used for longitudinal comparisons after log-transformation where required; between-group differences were assessed using the Brunner-Munzel test or the chi-square test. A P-value < 0.05 was considered statistically significant. Results: Each group comprised 35 patients with no significant differences in demographic, clinical, or echocardiographic characteristics. Procedure duration was longer with CBA (90 vs 70 min., p < 0.001). hs-cTn increased in both groups, with a higher peak (10217 ng/L vs 5831 ng/L, p = 0.034) and more rapid decline (6431 ng/L vs 4947 ng/L, p = 0.078) in the PFA group. CRP was higher after CBA (11.7 mg/L vs 4.5 mg/L, p < 0.001). D-dimer and creatinine did not change significantly. Biomarker changes were dependent on the time of sample collection and energy modality used, but not on the diameter of the ablation catheter. Conclusion: Compared to CBA, PFA is associated with a substantially greater early increase of hs-cTn within the first few hours, followed by a steeper decline by the following day. CRP increases more after CBA, while D-dimer and creatinine are not affected by either ablation modality.
No takes yet. Share an insight, caveat, or question.
Baltov et al. (2026) conducted an observational in Atrial fibrillation (n=70). Pulsed field ablation (PFA) vs. Cryoballoon ablation (CBA) was evaluated on Peak high-sensitivity cardiac troponin I (hs-cTn) 6-8 hours post-procedure (ng/L) (p=0.034). Compared to cryoballoon ablation, pulsed field ablation resulted in a significantly higher early peak of high-sensitivity cardiac troponin (10,217 vs 5,831 ng/L).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: